Clinical Trials Logo

Children clinical trials

View clinical trials related to Children.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 2

NCT ID: NCT05247099 Not yet recruiting - Children Clinical Trials

Pediatric Eye Care Investigated Team

PECT
Start date: February 2022
Phase:
Study type: Observational

Use cohort research to analyze and compare eyes of healthy children and children with systemic diseases. Understand and analyze the incidence, characteristics and influencing factors of children's ocular surface diseases. Establish a multi-center children's eye data sharing platform to provide basic data support for the diagnosis and treatment of children's ocular surface diseases.

NCT ID: NCT05185973 Not yet recruiting - Malnutrition Clinical Trials

Effects of "For-Baby" Supplementation on Young Children's Physical Growth and Diarrhea Episodes

LaoBiome
Start date: March 20, 2022
Phase: N/A
Study type: Interventional

The LaoBiome Study is a community-based, randomized, placebo-controlled trial with two study arms conducted in Lao People's Democratic Republic. This study aims at providing evidence on impact of For-baby powder supplement on child physical growth, diarrheal incidence, environmental enteric dysfunction, adherence to the intervention, and neuro-behavioural development of: 1) daily administration of For-Baby powder supplements (Intervention Group) and 2) daily administration of micronutrient powder (Placebo-Controlled Group).

NCT ID: NCT04999241 Not yet recruiting - Ulcerative Colitis Clinical Trials

Combined Application of EEN in the Induction of Remission in PUC

Start date: March 1, 2024
Phase: Phase 4
Study type: Interventional

The role of exclusive enteral nutrition (EEN) in the induction of remission in pediatric patients with Crohn's disease had been well documented. But the role of EEN in children with Ulcerative Colitis (UC) was not clear. In this study, EEN will be combined with corticosteroids or infliximab in the induction of remission in pediatric UC patients with moderate to severe disease activity. The mucosal healing rate at week12 will be compared between the two groups (combine with EEN group VS non-combine group).

NCT ID: NCT03821181 Not yet recruiting - Stroke Clinical Trials

The Effect of RIC on TIA/Stroke in Children With Moyamoya Disease

RIC-PMD-1
Start date: December 8, 2019
Phase: N/A
Study type: Interventional

Moyamoya disease is a common reason of transient ischemic attack (TIA) and stroke in children. Remote ischemic conditioning (RIC) has been shown to prevent recurrent stroke in intracranial arterial stenosis, but it is unclear whether RIC can prevent TIA or stroke in children with moyamoya disease. This study aims to evaluate the effect of RIC on TIA/stroke in children with moyamoya disease.

NCT ID: NCT03427697 Not yet recruiting - Myopia Clinical Trials

Effect of VR and Accommdation Relax on Controlling Myopia in Children

Start date: September 18, 2020
Phase: N/A
Study type: Interventional

This study evaluates the effect of virtual reality and accommodation relax technique on controlling onset and development of myopia in school-aged children. Half of the children will receive head-mounted video display which shows video with virtual reality and accommodation relax technique in combination, while the other half will receive no intervention.

NCT ID: NCT02601742 Not yet recruiting - Diarrhea Clinical Trials

Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute

Start date: November 2015
Phase: Phase 3
Study type: Interventional

Acute diarrhea is the third cause of infant mortality in the world causing 15% of all deaths in children under 5 years and is responsible for nearly 1.4 million deaths in developing countries. It is considered a self-limiting disease and to this problem the recommendation of the World Health Organization (WHO) is the administration of zinc with low osmolarity oral dehydration salts for a period of 10-14 days which reduces the severity of the episode. In Mexico COFEPRIS believes the zinc salt as a food supplement and not a drug and the above problem is presented in terms of prescribing and access of this salt to the general population. In Mexico the investigators have the provision and accessibility of low osmolarity oral dehydration salts supplemented with adequate doses of zinc, which is inexpensive for the general population and offering a solution in terms of supply and management. The purpose of the study involves the evaluation Pedialyte diarrhea in the treatment of acute diarrhea in children under 5 years. The investigator sconsider the use of Pedialyte diarrhea eases their access to the population in general and it is low cost compared with the zinc salt that is sold only in specialized pharmacies under strict medical prescription Objective: Compare the duration of symptoms of acute diarrhea in the treatment with low osmolarity oral rehydration salts (Pedialyte) vs treatment of low osmolarity oral rehydration supplemented with zinc (Pedialyte diarrhea) Study Desing: Double blind, randomized, controlled.

NCT ID: NCT02408302 Not yet recruiting - Children Clinical Trials

Buccal Midazolam Versus Nasal or Oral Midazolam Sedation for Minor Invasive Procedures in Children

Start date: April 2015
Phase: Phase 4
Study type: Interventional

Currently Midazolam sedation is the standard of care for minor invasive procedures in pediatric patients; its use is restricted to two routes of administration for this purpose oral and intranasal. A third route of administration (buccal) is tested and approved for seizure management. In the investigators' study the researchers investigate the buccal route of administration versus oral or intranasal administration for sedation. The investigators' hypothesis is that buccal route of administration is more convenient than intranasal and better absorbed than oral.